Arbet-Engels Christophe 4
4 · Millendo Therapeutics, Inc. · Filed May 27, 2020
Insider Transaction Report
Form 4
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-05-25+80,000→ 80,000 totalExercise: $2.00Exp: 2030-05-24→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date.